29 results
ARS
2023 FY
TARS
Tarsus Pharmaceuticals Inc
26 Apr 24
Annual report to shareholders
4:27pm
149 Item 10. Directors, Executive Officers and Corporate Governance 149 Item 11. Executive Compensation 149 Item 12. Security Ownership of Certain … governance and are reviewed quarterly by our Board of Directors. As of December 31, 2023, we've implemented a set of comprehensive cybersecurity and data
ARS
2022 FY
TARS
Tarsus Pharmaceuticals Inc
26 Apr 23
Annual report to shareholders
4:08pm
. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 133 Part III 134 Item 10. Directors, Executive Officers and Corporate Governance 134 Item … , and other accompanying compliance and governance costs). Other Income (Expense), Net Other income (expense), net primarily consists of (i) interest
CORRESP
vx0l3r t1s5
13 Apr 23
Correspondence with SEC
12:00am
8-K
uqnzpzzfsa5xx8919
7 Dec 22
Departure of Directors or Certain Officers
8:49am
8-K
tp81w j58ja8i3g7
12 Oct 22
Departure of Directors or Certain Officers
4:21pm
8-K
mk7y4mvhg
4 Jan 22
Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
4:15pm
8-K
EX-99.1
62nso62
4 Jan 22
Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
4:15pm
8-K
5g19vt6m ck
12 Aug 21
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors
4:01pm
DEF 14A
nie3sfil29j3f zwl3v
30 Apr 21
Definitive proxy
4:03pm
10-K
6mqen1h
31 Mar 21
Annual report
5:01pm